Fresh Recalls

FDAClass II · Medical device · Recall Z-2775-2026 · Recalled July 29, 2026

SnapshotGLO Wound Imaging Device recall — KENT IMAGING, INC.

Agency report date: July 29, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
SnapshotGLO Wound Imaging Device
Company / brand
KENT IMAGING
Lot / serial / date codes
UDI-DI: B376KB1000, Software Revisions v4.2.0 and v4.1.3
Distribution
US Nationwide distribution in the states of PA, IA, FL, TX, GA, NV, CA, UT, IN, DC, KS, IL, TN, AR, AZ.
Agency product description and boundaries

SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/ unavailable for wound imaging until corrected.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: SnapshotGLO Wound Imaging Device

3. Open the official notice or contact

Official recall ID
Z-2775-2026
Brand
KENT IMAGING
Classification
Class II
Units affected
77
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Calgary, N/A, Canada
Firm address
1210 8 St Sw Suite 300, N/A, N/A

Identifying details (verbatim from the notice)

Product codes / lots
UDI-DI: B376KB1000, Software Revisions v4.2.0 and v4.1.3
Distribution
US Nationwide distribution in the states of PA, IA, FL, TX, GA, NV, CA, UT, IN, DC, KS, IL, TN, AR, AZ.
Firm notified the public via
N/A
FDA event ID
99406
Recall initiated
June 30, 2026
FDA classified
July 22, 2026
FDA report date
July 29, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page